Search Count: 19
 |
Structure Of Methionyl-Trna Synthetase In Complex With N-(1H-Benzimidazol-2-Ylmethyl)-N'-(2,4-Dichlorophenyl)-6-(Morpholin-4-Yl)-1,3,5-Triazine-2,4-Diamine
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2015-07-29 Classification: LIGASE/LIGASE INHIBITOR Ligands: MG, 3BJ |
 |
Structure Of Methionyl-Trna Synthetase In Complex With 1-(4-{4-[(1H-Benzimidazol-2-Ylmethyl)Amino]-6-(4,5-Dimethoxy-2-Methylphenoxy)Pyrimidin-2-Yl}Piperazin-1-Yl)Ethanone
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-07-29 Classification: LIGASE/LIGASE INHIBITOR Ligands: 3BG, ATP, MG |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Enterococcus faecalis
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: 0WT, GOL |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic
Organism: Enterococcus faecalis
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: SUY, GOL |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity
Organism: Enterococcus faecalis
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: CJC, GOL |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Enterococcus faecalis
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: 1A0, TBU |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Francisella tularensis subsp. holarctica
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2013-02-13 Classification: isomerase/isomerase inhibitor Ligands: 19Y |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Francisella tularensis subsp. holarctica
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-02-13 Classification: isomerase/isomerase inhibitor Ligands: 19X |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Francisella tularensis subsp. holarctica lvs
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: CJC |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: 1A1, MG |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity.
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: 1AV, MG |
 |
Pyrrolopyrimidine Inhibitors Of Dna Gyrase B And Topoisomerase Iv, Part I: Structure Guided Discovery And Optimization Of Dual Targeting Agents With Potent, Broad-Spectrum Enzymatic Activity
Organism: Enterococcus faecalis
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2013-02-13 Classification: Isomerase/Isomerase inhibitor Ligands: 19Y |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: NAP, Q11 |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: NAP, Q12 |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: NAP, Q19 |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: Q20, NAP |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: M23, NAP |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: NAP, Q26 |
 |
S. Aureus Dihydrofolate Reductase Complexed With Novel 7-Aryl-2,4-Diaminoquinazolines
Organism: Staphylococcus aureus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-08-31 Classification: OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR Ligands: Q27, NAP |